Greenleaf Peter — SEC Form 4 filings
SEC reporting owner CIK 1363683. 11 Form 4 filings on record with FilingPulse; latest filed 2026-07-07.
Transaction summary — filings shown
Covers all 11 filings on record, filed 2024-02-22 to 2026-07-07. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 8 legs across 5 filings — 522,162 shares, $3,909,867 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 13.
- Largest priced transaction: sale of 195,593 shares @ $8.00 ($1,564,744) in Aurinia Pharmaceuticals Inc., filed 2025-03-04.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Aurinia Pharmaceuticals Inc. (AUPH) | Chief Executive Officer, Director | 7 | — | 4 legs · 520,568 sh · $3,872,371 | 10 |
| Pelthos Therapeutics Inc. (PTHS) | Director | 4 | — | 4 legs · 1,594 sh · $37,497 | 3 |
Form 4 filings — Greenleaf Peter
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-07 | 4 | Pelthos Therapeutics Inc. (PTHS) | Sale (S): 712 @ $26.00 · Sale (S): 85 @ $27.27 | EDGAR |
| 2026-04-06 | 4 | Pelthos Therapeutics Inc. (PTHS) | Sale (S): 420 @ $20.52 · Sale (S): 377 @ $21.36 | EDGAR |
| 2026-04-01 | 4/A | Pelthos Therapeutics Inc. (PTHS) | Grant/award (A): 25,478 @ $0 | EDGAR |
| 2026-03-03 | 4 | Aurinia Pharmaceuticals Inc. (AUPH) | Grant/award (A): 196,403 @ $0 · Tax withholding (F): 100,890 @ $14.21 · Grant/award (A): 328,424 (derivative) @ $0 | EDGAR |
| 2026-02-23 | 4 | Aurinia Pharmaceuticals Inc. (AUPH) | Tax withholding (F): 100,171 @ $14.40 | EDGAR |
| 2026-01-05 | 4 | Aurinia Pharmaceuticals Inc. (AUPH) | Grant/award (A): 165,384 @ $0 · Tax withholding (F): 113,169 @ $15.95 | EDGAR |
| 2025-07-07 | 4 | Pelthos Therapeutics Inc. (PTHS) | Grant/award (A): 25,478 (derivative) · Grant/award (A): 77,640 (derivative) | EDGAR |
| 2025-03-04 | 4 | Aurinia Pharmaceuticals Inc. (AUPH) | Grant/award (A): 290,728 @ $0 · Grant/award (A): 333,705 @ $0 · Sale (S): 195,593 @ $8 · Sale (S): 164,947 @ $7.92 · Grant/award (A): 443,973 (derivative) @ $0 | EDGAR |
| 2024-03-07 | 4 | Aurinia Pharmaceuticals Inc. (AUPH) | Sale (S): 126,981 @ $5.60 | EDGAR |
| 2024-02-22 | 4/A | Aurinia Pharmaceuticals Inc. (AUPH) | Sale (S): 33,047 @ $8.78 | EDGAR |
| 2024-02-22 | 4 | Aurinia Pharmaceuticals Inc. (AUPH) | Grant/award (A): 661,538 @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1363683 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →